HOSPITAL REPORT
|
By joining together with other hospitals on medication purchasing and other efforts, Kalispell Regional Medical Center in Kalispell, Mt., has saved millions of dollars annually. More |
|
ANTICOAGULATION
Interim data from the REVERSE-AD study suggests that idarucizumab is safe and effective for reversing the anticoagulant effects of dabigatran.
More |
EDITOR'S CHOICE
FDA recently approved Novartis' Entresto, a twice-daily therapy formulated to reduce risk of cardiovascular death and hospitalization for patients with chronic heart failure and reduced ejection fraction. More |
Inside The Latest Issue
|
|
|
